HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparative efficacy of five antibiotics on experimental airborne legionellosis in guinea-pigs.

Abstract
The efficacy of preventive and curative treatment of experimental airborne legionellosis in guinea-pigs was studied for erythromycin, rifampicin, minocycline, doxycycline and pefloxacin. The aerosol was produced from a strain of Legionella pneumophila serogroup 1 and dispersed in a chamber maintained below atmospheric pressure. Guinea-pigs were exposed for 30 min to 1 or 10 LD50 (10(3) or 10(4) viable inhaled organisms). Treatment was preventive or curative. Antibiotic concentrations in lungs and serum were evaluated during treatment. The action of the antibiotics on guinea-pigs infected by 1 LD50 resulted in 100% survival. For the 10 LD50 infection, pefloxacin, minocycline and erythromycin were more active (with 87.5% survivors) than doxycycline (75%) and rifampicin (62.5%). Preventive treatment with pefloxacin or doxycycline gave 100% protection, compared with 87.5% for rifampicin, 50% for erythromycin and 37.5% for minocycline. In this study, treatment of experimental legionellosis was improved, compared with previous publications, by early administration of antibiotics and increased dosage and duration.
AuthorsM Nowicki, J C Paucod, N Bornstein, H Meugnier, P Isoard, J Fleurette
JournalThe Journal of antimicrobial chemotherapy (J Antimicrob Chemother) Vol. 22 Issue 4 Pg. 513-9 (Oct 1988) ISSN: 0305-7453 [Print] England
PMID3204078 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Anti-Bacterial Agents
Topics
  • Animals
  • Anti-Bacterial Agents (administration & dosage, therapeutic use)
  • Guinea Pigs
  • Legionnaires' Disease (drug therapy, prevention & control)
  • Lethal Dose 50
  • Male
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: